Cytocentric Blog
Cytocentric Visionaries: Adrien Moya p1
Cytocentric Visionaries: Dr. Adrien Moya, University of Miami Part 1: Oxygen and Glucose for Engineering Tissues Dr. Adrien Moya has just started a post-doc at the University of Miami in the lab of Paul Schiller. Here we discuss Dr. Moya’s...
Cytocentric Visionaries Budd Tucker p2
Cytocentric Visionary: Budd Tucker, University of Iowa Part 2: Modularity is Key to Cell Therapy Process Flexibility Dr. Budd Tucker is the Stephen A. Wynn Associate Professor of Regenerative Ophthalmology at the Stephen A. Wynn...
Cytocentric Visionaries Budd Tucker p1
Cytocentric Visionary: Budd Tucker, University of Iowa With iPSC and CRISPR, Leave Nobody Behind, Leave Nobody Blind Dr. Budd Tucker is the Stephen A. Wynn Associate Professor of Regenerative Ophthalmology at the Stephen A. Wynn...
Top 5 Cytocentric Publications of 2017
Top 5 Cytocentric Publications of 2017 With the first approvals of CAR-T, 2017 was a big year for cell-based research and therapies. Some scientific publications stood out from the rest as far as Cytocentric™ advancement. These...
Interviews with outstanding researchers that are changing, at a fundamental level, our understanding of the in vitro world.
The Biology of HIF Proteins Impacts the Outcome of Your Experiments in Physiologic Oxygen
The Biology of HIF Proteins Impacts the Outcome of Your Experiments in Physiologic Oxygen: Considerations for protocol design We recently posted an article “What Oxygen Level Should I Use for My Cells In Vitro?” in response to questions that we...
Mesenchymal Stem Cells for Cellular Therapies and Regenerative Medicine
Mesenchymal Stem Cells for Cellular Therapies and Regenerative Medicine: Cytocentric oxygen control makes sense from the molecular level through to the bottom line. Mesenchymal stem cells (MSC) have shown tremendous promise as a cellular...
What oxygen level should I use for my cells in vitro
What Oxygen Level Should I Use for My Cells In Vitro? Well, it depends. Learning how to determine oxygen levels for your in vitro culture is important to producing relevant results. Are you looking for physiological relevance or comparison...
Biocontainment Cells Need Technician Protection
Biocontainment: Cells Need Technician Protection “I’ve been handling cells this way for years and I’VE never gotten sick.” How many times have you heard that, and doubted it? Continue reading to learn why biosafety and biocontainment have...
In Vitro Reproducibility and Experimental Conditions
In Vitro Reproducibility and Experimental Conditions: Is There an Elephant in the Room Air? If another lab tried to reproduce your results, would they fail? It’s a scary thought. Amongst the recent publications on the Crisis in...
Cytocentric Visionaries Tim Downing p3
Cytocentric Visionaries: Tim Downing, PhD Part Three: How Does the Question You Are Asking Change, in the Physiological Context, if You Are Not Working In Vivo? This post contains excerpts from an interview that Dr. Alicia Henn, Chief...
Cytocentric Visionaries Tim Downing p2
Cytocentric Visionaries: Tim Downing, PhD Part Two: Physiologic Simulation: You Can Never Step in the Same River Twice This post contains excerpts from an interview that Dr. Alicia Henn, Chief Scientific Officer of BioSpherix, conducted with...
Cytocentric Visionaries Tim Downing p1
Cytocentric Visionaries: Tim Downing, PhD Part One: Understanding the Effect of the In Vitro Microenvironment on the Epigenomics of Cell Reprogramming This post is part of a three-part series from an interview that Dr. Alicia Henn, Chief...
Cytocentric Visionaries Roger Ronn p5
Cytocentric Visionaries: Roger Rönn Part Five: Unbroken Optimized Conditions for Hematopoietic Stem Cells. This is a five-part series of blog posts containing excerpts from an interview that Dr. Alicia Henn, Chief Scientific Officer of...
Cytocentric Visionaries Roger Ronn p4
Cytocentric Visionaries: Roger Rönn Part Four: Physiologic Simulation for Hematopoietic Stem Cells This is a five-part series of blog posts containing excerpts from an interview that Dr. Alicia Henn, Chief Scientific Officer of BioSpherix,...